Delayed Treatment with Plasminogen Activator Inhibitor-1 Decoys Reduces Tubulointerstitial Fibrosis (Q57718662)

Bénédicte Buffin-Meyer

12

0 references

Julie Klein

Julie Klein

2

0 references

Joost P Schanstra

Joost P. Schanstra

11

0 references

Jean-Loup Bascands

Jean-Loup Bascands

10

0 references

author name string

Julien Gonzalez

1

0 references

Sharmila D. Chauhan

3

0 references

Eric Neau

4

0 references

Denis Calise

5

0 references

Caroline Nevoit

6

0 references

Rana Chaaya

7

0 references

Mathieu Miravete

8

0 references

Christine Delage

Experimental Biology and Medicine

9

0 references

publication date

December 2009

0 references

published in

0 references

volume

234

0 references

issue

12

0 references

page(s)

1511-1518

0 references

cites work

Chronic kidney disease: the global challenge

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Pentoxifylline inhibits transforming growth factor-beta signaling and renal fibrosis in experimental crescentic glomerulonephritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

In vivo bradykinin B2 receptor activation reduces renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Plasmin(ogen) Promotes Renal Interstitial Fibrosis by Promoting Epithelial-to-Mesenchymal Transition: Role of Plasmin-Activated Signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Loss of TIMP3 enhances interstitial nephritis and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Human plasma fibronectin as a substrate for human urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

The low density lipoprotein receptor-related protein mediates fibronectin catabolism and inhibits fibronectin accumulation on cell surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105

Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0903-RM-105